Cite
HARVARD Citation
Zhou, Y. et al. (2021). Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials. Diabetic medicine. 38 (1), p. n/a. [Online].